You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GBM

Showing 851 - 875 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gliosarcoma, Glioblastoma, Anaplastic Astrocytoma Trial in Durham (Temodar and SCH 66336)

Completed
  • Gliosarcoma
  • +2 more
  • Temodar and SCH 66336
  • Durham, North Carolina
    Duke University Health System
Feb 15, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Zactima, Gleevec, Hydroxyurea)

Completed
  • Glioblastoma
  • Gliosarcoma
  • Zactima, Gleevec, Hydroxyurea
  • Durham, North Carolina
    Duke University Health System
Dec 4, 2012

Combined O-(2-[18F]Fluoroethyl)-L-tyrosine Positron Emission

Unknown status
  • Glioblastoma
  • +8 more
    • Munich, Bavaria, Germany
      University of Munich, Dep. of Radiation Oncology
    Dec 17, 2012

    Malignant Tumors of Eye, Brain and Other Parts of CNS Trial in United States (carmustine, radiation therapy, O6-Benzylguanine)

    Completed
    • Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    • Anchorage, Alaska
    • +162 more
    Jan 28, 2013

    Glioblastoma Multiforme Trial in Houston (Temodar (Temozolomide), Hominex-2)

    Terminated
    • Glioblastoma Multiforme
    • Temodar (Temozolomide)
    • Hominex-2
    • Houston, Texas
      U.T.M.D. Anderson Cancer Center
    Jan 12, 2012

    Anaplastic Glioma Trial in Caen (18F-FMISO PET-scanning)

    Completed
    • Anaplastic Glioma
    • 18F-FMISO PET-scanning
    • Caen, France
      Caen University Hospital
    Nov 16, 2012

    Glioblastoma, Gliosarcoma Trial in Durham (hydroxyurea, imatinib mesylate)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • Durham, North Carolina
      Duke Cancer Institute
    Jan 14, 2013

    Glioblastoma Multiforme Trial in Copenhagen, Odense, Århus (bevacizumab and Irinotecan and radiotherapy, Bevacizumab and

    Completed
    • Glioblastoma Multiforme
    • bevacizumab and Irinotecan and radiotherapy
    • Bevacizumab and Temozolomide and radiotherapy
    • Copenhagen, Denmark
    • +2 more
    Nov 29, 2011

    Brain and CNS Tumors Trial in Canada (temozolomide, radiation therapy)

    Completed
    • Brain and Central Nervous System Tumors
    • Calgary, Alberta, Canada
    • +15 more
    Sep 20, 2012

    Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography

    Completed
    • Glioblastoma Multiforme
      • Freiburg, Baden Wuertemberg, Germany
      • +2 more
      Aug 5, 2012

      Naive Unresectable Glioblastoma Trial in Dijon (Avastin + Campto / radiotherapy + Temodal + Avastin (4 cures),

      Completed
      • Naive Unresectable Glioblastoma
      • Dijon, Bourgogne, France
        Centre Georges François Leclerc
      Sep 24, 2012

      Anaplastic Astrocytoma, Glioblastoma Trial in Tampa (Sunitinib Malate)

      Completed
      Has Results
      • Anaplastic Astrocytoma
      • Glioblastoma
      • Sunitinib Malate
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Nov 13, 2012

      Glioblastoma Multiforme Trial in United States (Everolimus, Surgery)

      Terminated
      Has Results
      • Glioblastoma Multiforme
      • Los Angeles, California
      • +7 more
      Sep 20, 2011

      Cancer Stem Cells Using iFP Technique

      Unknown status
      • Malignant Neoplasm of Breast
      • +2 more
        • Haifa, Israel
          Rambam Health Care Campus
        Jul 11, 2012

        Brain and CNS Tumors Trial in United States (drug, procedure, radiation)

        Completed
        • Brain and Central Nervous System Tumors
        • Birmingham, Alabama
        • +7 more
        May 1, 2012

        Glioblastoma Multiforme Trial in Clermont Ferrand, Toulouse (Zarnestra, standard Radiation therapy)

        Completed
        • Glioblastoma Multiforme
        • Clermont Ferrand, France
        • +1 more
        Nov 23, 2011

        Glioblastoma Trial in Houston (Aspirin, Placebo)

        Terminated
        Has Results
        • Glioblastoma
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        Nov 4, 2011

        Glioblastoma Trial in Boston (Radiologic exams)

        Terminated
        • Glioblastoma
        • Radiologic exams
        • Boston, Massachusetts
          Massachusetts General Hospital
        Jan 4, 2012

        Glioblastoma Multiforme Trial in Stanford, Houston (Verubulin, Temozolomide & Radiation Therapy)

        Completed
        • Glioblastoma Multiforme
        • Stanford, California
        • +1 more
        Apr 10, 2012

        Glioblastoma Multiforme Trial (Neuradiab + Radiotherapy + Temozolomide, Radiation Therapy + Temozolomide)

        Terminated
        • Glioblastoma Multiforme
        • Neuradiab + Radiotherapy + Temozolomide
        • Radiation Therapy + Temozolomide
        • (no location specified)
        Feb 8, 2011

        Enalapril in Collagen Type 4 Nephropathy

        Completed
        • Collagen Type-4 Nephropathies
          • (no location specified)
          Nov 1, 2011

          Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular Trial (Crizotinib plus VEGF inhibitor combinations, Crizotinib

          Withdrawn
          • Carcinoma, Renal Cell
          • +2 more
          • Crizotinib plus VEGF inhibitor combinations
          • +4 more
          • (no location specified)
          Dec 19, 2011

          Resection of Glioblastoma by 5-Aminolevulinic Acid and

          Unknown status
          • Glioblastoma
          • diagnostic 5-ALA and MRI for tumor resection
          • Zurich, Switzerland
            UniversitätsSpital Zürich
          Oct 21, 2010

          NSCLC, NSCLC Trial in Switzerland (NovoTTF-100L)

          Completed
          • Non-small Cell Lung Cancer
          • NSCLC
          • NovoTTF-100L
          • Basel, Switzerland
          • +3 more
          Sep 26, 2011

          Glioma Trial run by the NCI (PEG-interferon alfa-2b, Thalidomide)

          Completed
          Has Results
          • Glioma
          • Bethesda, Maryland
            National Institutes of Health
          Sep 19, 2011